[扩散型大B细胞淋巴瘤表达高水平的甘甲3-酸盐脱酶并发症与低血糖症]
Shiho Hirano1, Akari Iwakoshi2, Nobuhiko Imahashi1
1Department of Hematology, National Hospital Organization Nagoya Medical Center.
概括
这项研究发现,淋巴瘤细胞可以通过摄入过多的葡萄糖引起低血糖症. 在扩散型大B细胞淋巴瘤 (DLBCL) 中,酶甘甲基3-酸脱酶的水平升高表明高糖分活性,导致低血糖症.
科学领域:
- 在瘤学瘤学.
- 代谢医学是一种代谢医学.
背景情况:
- 低血糖症是一种复杂的疾病,有各种潜在原因.
- 扩散性大B细胞淋巴瘤 (DLBCL) 是一种侵略性的非霍奇金淋巴瘤.
- 淋巴瘤相关的低血糖症可能很难管理.
研究的目的:
- 为了研究DLBCL患者低血糖的机制.
- 探索增强型糖解在淋巴瘤诱导的低血糖症中的作用.
- 为了比较DLBCL中含有和不含低血糖的糖溶酶表达.
主要方法:
- 患者病例研究与临床数据分析.
- 准大动脉淋巴结活检用于DLBCL诊断.
- 在淋巴瘤组织中对甘甲基-3-酸盐脱酶 (GAPDH) 表达的定量分析.
主要成果:
- 这位患者呈现出低血糖症,壮症和副大动脉淋巴腺病,诊断为DLBCL.
- 低血糖症通过化疗得到缓解,这表明淋巴瘤相关的原因.
- 与没有低血糖症的DLBCL病例相比,在低血糖症的DLBCL病例中观察到显著更高的GAPDH表达.
- 这表明淋巴瘤细胞的糖分解析活性增加.
结论:
- DLBCL细胞通过高调 glycolysis 的增强葡萄糖消耗是低血糖的可能原因.
- GAPDH表达水平可以作为淋巴瘤相关低血糖症的生物标志物.
- 了解这种代谢联系可以为DLBCL低血糖患者的临床管理策略提供信息.
相关概念视频
Hypoglycemia and Glucagon
297
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
297
Glucose Transporters
22.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
Inborn Errors of Metabolism
194
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
194
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Diabetes: Symptoms, Diagnosis, and Complications
590
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
590


